Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,822,111
-
Number of holders
-
182
-
Total 13F shares, excl. options
-
70,389,436
-
Shares change
-
+3,876,772
-
Total reported value, excl. options
-
$838,494,071
-
Value change
-
+$42,500,929
-
Put/Call ratio
-
9.5%
-
Number of buys
-
89
-
Number of sells
-
-80
-
Price
-
$11.91
Significant Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q1 2025
205 filings reported holding ZYME - Zymeworks Inc. - Common Stock as of Q1 2025.
Zymeworks Inc. - Common Stock (ZYME) has 182 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70,389,436 shares
of 74,822,111 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (17,259,548 shares), Redmile Group, LLC (4,788,945 shares), Rubric Capital Management LP (4,338,444 shares), BVF INC/IL (4,308,935 shares), BlackRock, Inc. (4,089,421 shares), MORGAN STANLEY (4,073,463 shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (3,879,945 shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2,197,879 shares), PERCEPTIVE ADVISORS LLC (1,864,672 shares), and VANGUARD GROUP INC (1,767,041 shares).
This table shows the top 182 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.